Meribank Biotech Co., Ltd (4724.TWO)
TWD 15.55
(-3.12%)
TWD 15.55
(-3.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -123.15 Million TWD | -21.03% |
| 2022 | -102.83 Million TWD | -10.83% |
| 2021 | -92.78 Million TWD | -87.17% |
| 2020 | -49.57 Million TWD | 13.66% |
| 2019 | -57.41 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -23.48 Million TWD | 0.0% |
| 2024 Q1 | -23.48 Million TWD | 27.76% |
| 2023 Q3 | -32.5 Million TWD | -11.83% |
| 2023 FY | -124.45 Million TWD | -21.03% |
| 2023 Q2 | -29.06 Million TWD | 0.0% |
| 2023 Q1 | -29.06 Million TWD | 0.23% |
| 2023 Q4 | -32.5 Million TWD | 0.0% |
| 2022 FY | -102.83 Million TWD | -10.83% |
| 2022 Q4 | -29.13 Million TWD | 0.0% |
| 2022 Q3 | -29.13 Million TWD | 0.0% |
| 2021 FY | -92.78 Million TWD | -87.17% |
| 2020 FY | -49.57 Million TWD | 13.66% |
| 2019 FY | -57.41 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 143.695% |
| Level Biotechnology Inc. | 67.55 Million TWD | 282.31% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 25.914% |
| GlycoNex Incorporation | -259.86 Million TWD | 52.608% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 46.288% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 94.107% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -5366.223% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -44.897% |
| Visgeneer Inc. | -21.15 Million TWD | -482.041% |
| Neith Corporation | -48.85 Million TWD | -152.086% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 67.214% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 89.854% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -1763.147% |
| Enimmune corporation | -243.47 Million TWD | 49.418% |
| TaiRx, Inc. | -214.69 Million TWD | 42.638% |
| CHO Pharma, Inc. | -268.99 Million TWD | 54.218% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 294.449% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | -70.819% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 136.465% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 609.701% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -182.723% |
| RBC Bioscience Corporation | 14.53 Million TWD | 947.06% |
| NaviFUS Corp. | -76.42 Million TWD | -61.141% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 82.258% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -96.471% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -87.107% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -91.304% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -74.484% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -31.947% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 30.241% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 252.637% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -81.919% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 88.772% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -117.015% |
| AP Biosciences Inc | -347.47 Million TWD | 64.558% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 113.763% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 136.863% |
| EirGenix Inc. | -1.03 Billion TWD | 88.066% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -4260.977% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 79.546% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -170.656% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -196.885% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | -44.983% |
| VBI | -16.13 Million TWD | -663.414% |
| BiOptic Inc. | 44.05 Million TWD | 379.559% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -31.078% |
| Sinew Pharma Inc. | -186.25 Million TWD | 33.878% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 177.059% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 90.013% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -95.94% |
| Intech Biopharm Corporation | -304.39 Million TWD | 59.542% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 88.77% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 27.367% |
| TCI GENE Inc. | 10.04 Million TWD | 1325.535% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 3.224% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 60.415% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 41.964% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 3686.313% |
| PharmaEngine, Inc. | 277.18 Million TWD | 144.431% |
| Savior Lifetec Corporation | -2.42 Million TWD | -4989.008% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 29.505% |
| Acepodia, Inc. | -435.97 Million TWD | 71.752% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 74.761% |